Fundamental Analysis (FA)
Framework: DCF Benchmarked
Join Palmy To Bypass The Blur →
For PAT.DE
Valuation Weak
28%
Profitability n.A.
Fin. Growth Weak
33%
Leverage & Liquidity Weak
33%
Per Share Metrics Weak
33%
Fin. Health n.A.
Fundamental Analysis (FA)
Benchmarked
1 Financial Health
Metric Q4 Q1 Δ in %
Current Ratio 14.10 2.35 2.06
Debt/Assets n.A. n.A. n.A.
Debt/Equity n.A. n.A. n.A.
Net Debt/EBITDA 1227.32 28.81 2.17
Naive Interpretation member
2 Per Share
Metric Q4 Q1 Δ in %
Book Value 0.42 13.53 13.47
Cash 10.60 4.52 4.09
Capex -31.70 -0.07 -0.05
Free Cash Flow -99.18 < 0.005 0.44
Revenue -34.16 0.73 1.12
Naive Interpretation member
3 Profitability
Metric Q4 Q1 Δ in %
Gross Margin 26.72 0.82 0.65
Operating Margin 36.43 -0.09 -0.13
ROA -49.43 < 0.005 < 0.005
ROE -49.13 < 0.005 < 0.005
ROIC 71.87 < 0.005 < 0.005
Naive Interpretation member
4 Valuation
The "Valuation Entry" for the Focus of PAT.DE is permitted for members.
5 Growth
The "Growth Entry" for the Focus of PAT.DE is permitted for members.
6 Leverage & Liquidity
The "Leverage & Liquidity Entry" for the Focus of PAT.DE is permitted for members.